OHDSI Home | Forums | Wiki | Github

OHDSI virtual study-a-thon to support COVID-19 response, to take place 26-29Mar2020...Collaborators wanted!


(Craig Sachson) #42

Hi @Qubit,
Unfortunately, registration has closed on the study-a-thon. However, this is only the beginning of OHDSI’s research agenda around the COVID-19 pandemic. You can get a sense of the planned studies from this recent forum post, and then follow along on the forum, our COVID-19 updates page, or on our Twitter or LinkedIn feeds. We hope you will consider collaborating with our community on the many future efforts to support healthcare decision-making.

Best,
Craig


(Craig Sachson) #43

Hi @CJ_Hameed,
Unfortunately, registration has closed on the study-a-thon. However, this is only the beginning of OHDSI’s research agenda around the COVID-19 pandemic. You can get a sense of the planned studies from this recent forum post, and then follow along on the forum, our COVID-19 updates page, or on our Twitter or LinkedIn feeds. We hope you will consider collaborating with our community on the many future efforts to support healthcare decision-making.

Best,
Craig


(Craig Sachson) #44

Hi @Andy_Kanter,
Unfortunately, registration has closed on the study-a-thon. However, this is only the beginning of OHDSI’s research agenda around the COVID-19 pandemic. You can get a sense of the planned studies from this recent forum post, and then follow along on the forum, our COVID-19 updates page, or on our Twitter or LinkedIn feeds. We hope you will consider collaborating with our community on the many future efforts to support healthcare decision-making.

Best,
Craig


#45

Hi everyone,

Thank you for this great initiative! I am Lotte Geys and I work as a community manager for the Multiple Sclerosis Data Alliance (MSDA).
To reduce symptoms in MS patients, disease-modifying therapies (DMT’s) are given, but these therapies are often immune-suppressants. Since we would like to inform our MS patients (whether or not infected with SARS-COV2) in the best possible way about whether they should stop or change their DMT’s, we have the following urgent question:
Is there an increased risk of severe COVID-19 outcomes when using immune-suppressing drugs?

Apart from MS patients there are of course other immunocompromised patients. It would be of interest if anyone could share his/her experience with COVID19 in patients suffering from other immune-diseases on different medications as well, or oncology patients that are immune-suppressed.

Additionally, will we be able to ask and discuss such questions during the COVID-19 study-a-thon of the upcoming days?

Thanks!


(Weihua Gao) #47

Hi Patrick, I have registered this study group. But I did not get an email from Microsoft Teams OHDSI-COVID-19 with instructions for how to log on. May you or other team member send me that invitation email. My email is weihua.gao@abbvie.com. Thanks!


(Craig Sachson) #48

Hi @gaowx3, I have reached out to the group running the @MSTeams account and asked them to re-send the email. It might be in the morning, though. I do see you registered, so you are in.


(Weihua Gao) #49

Thank you for the prompt response!


(Seng Chan You) #50

The Korean government launched the distributed research network project for COVID-19
#opendata4covid19


(George Hripcsak) #51

It is spectacular for the Korean government to do this! It will be a great help for the entire world and hopefully accelerate the control of COVID-19. Everyone everywhere is waiting for the evidence that the data will generate. OHDSI is very pleased to assist them in analyzing the data.


(Guy Tsafnat) #52

Thank you Chan. This is a great resource. Can you only access the data via R and SAS or can you also use other tools? ML? NLP? Python?


(Christian Reich) #53

Is it the Korean Government, or Chan convincing the Korean Government? :slight_smile:
Either way: it’s an example for the world.


(Joshua Vogelstein) #54

That’s great news Chan! Do you know when it will be available and how individuals can get access?


(Chiara Attanasio) #55

Hi everyone!

Apparently there has been some oncology-related questions during the OHDSI COVID-19 studyathon, so this message is mainly for those people interested in COVID&CANCER:

The OncologyWG is organizing a Covid-Oncology use case session next week to mainly:

  1.  Assess available data on COVID-19 in relation to cancer;
    
  2.  Overview the clinical use cases on cancer patients in relation with COVID-19;
    
  3.  Identify matches between data and use case, and an action plan to perform a study.
    

In case you’re interested in contributing or you’d like to know more about it, feel free to drop me a message!

Cheers,
Chiara


(Julianna Kohler) #56

@CraigSachson I also registered and haven’t gotten any emails from @MSTeams. Is it possible to check and make sure I’m registered? I seem to be having some problems receiving the emails–it might be better to use my personal email, juliannamkohler@gmail.com.


(Craig Sachson) #57

@julie_kohler I’m sorry you didn’t get an email yet … I’ve reached out and asked them to retry with your new email. Please check there. Thank you!


(Julianna Kohler) #58

Thank you, @CraigSachson!


(Jeremy Warner) #59

Hi Chiara, please loop me into this, as you might know we’ve launched a US-based consortium, the COVID-19 and Cancer Consortium and are in process of adding international partners. Working directly with Michael Gurley towards making our survey OMOP-compatible.

Best,
Jeremy


(Weihua Gao) #60

Hi all,

I’m trying to run “Covid19CohortEvaluation” package using R studio at my end. I encountered connection issue. I usually connect IMAPLA server using the following codes
require(odbc)
require(implyr)
require(dplyr)

driver <- odbc::odbc()
impala <- src_impala(drv = driver, dsn = “IMPALA_PROD”)

Now the package use the following code to connect impala, I got error message.
connectionDetails <- createConnectionDetails(dbms = “odhc”,
server = Sys.getenv(“ua00745pk.abbvienet.com”),
user = “xxxxx”,
password = “xxxxx”,
port = Sys.getenv(“21050”),
schema = “rwd_p_omop_truven_commercial_cdm2”)
conn <- connect(connectionDetails)
dbGetQuery(conn, “SELECT COUNT(*) FROM person”)

Here is error message I got
Error in (function (classes, fdef, mtable) :
unable to find an inherited method for function ‘dbGetQuery’ for signature ‘“NULL”, “character”’

May you give me some suggestions how to solve the error? Thank you very much!


(Martijn Schuemie) #61

Your code shows you use a connectionDetails object that is not defined? Please call createConnectionDetails first.


(Ajit Londhe) #62

Can you try instead using

connectionDetails <- createConnectionDetails(dbms = "impala",
server = Sys.getenv("ua00745pk.abbvienet.com"),
user = "xxxxx",
password = "xxxxx",
port = Sys.getenv("21050"),
schema = "rwd_p_omop_truven_commercial_cdm2")

t